Back to 
TWO SIGMA ADVISERS, LP
TWO SIGMA ADVISERS, LP
MCRB
Showing 0 of 18 quarters
Position history for TWO SIGMA ADVISERS, LP's holdings in SERES THERAPEUTICS INC
No. Two Sigma Advisers exited its MCRB (Seres Therapeutics) position in Q1 2023. Its Q4 2022 13F listed 19,700 shares worth $110,320. Two Sigma Advisers already held MCRB in its Q4 2018 13F, the earliest on record, and held it in 17 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.